Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma
NCT00843193
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
198
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
INTRAVENOUS GSK679586
DRUG:
INTRAVENOUS PLACEBO
DRUG:
FLUTICASONE PROPIONATE
Sponsor
GlaxoSmithKline